Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Citi
Healthtrust
Fish and Richardson
Teva
Cerilliant
Deloitte
Johnson and Johnson
Fuji

Generated: September 19, 2018

DrugPatentWatch Database Preview

Gentamicin sulfate - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for gentamicin sulfate and what is the scope of gentamicin sulfate patent protection?

Gentamicin sulfate is the generic ingredient in twelve branded drugs marketed by Schering, Pharmafair, Alpharma Us Pharms, Fougera Pharms Inc, G And W Labs Inc, Perrigo New York, Pharmaderm, Taro, King Pharms, Bristol, Intl Medication, Abbott, Fresenius Kabi Usa, Hospira, Kalapharm, Pharm Spec, Solopak, Teva Parenteral, Watson Labs, West-ward Pharms Int, Wyeth Ayerst, B Braun, Baxter Hlthcare, Pharmacia And Upjohn, Novartis, Akorn, Perrigo Co Tennessee, Allergan, Alcon Pharms Ltd, Bausch And Lomb, Paco, and Sandoz Inc, and is included in fifty-nine NDAs. Additional information is available in the individual branded drug profile pages.

There are fifteen drug master file entries for gentamicin sulfate. Twenty-nine suppliers are listed for this compound.

Summary for gentamicin sulfate
Pharmacology for gentamicin sulfate

US Patents and Regulatory Information for gentamicin sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Kalapharm GENTAMICIN SULFATE gentamicin sulfate INJECTABLE;INJECTION 062354-001 Apr 5, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Novartis GENTACIDIN gentamicin sulfate SOLUTION/DROPS;OPHTHALMIC 062480-001 Mar 30, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bristol BRISTAGEN gentamicin sulfate INJECTABLE;INJECTION 062288-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Solopak GENTAMICIN SULFATE gentamicin sulfate INJECTABLE;INJECTION 062507-001 Jun 6, 1985 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Intl Medication GENTAMICIN gentamicin sulfate INJECTABLE;INJECTION 062325-004 Jun 23, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Alpharma Us Pharms GENTAMICIN SULFATE gentamicin sulfate OINTMENT;TOPICAL 062496-001 Mar 14, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharmafair GENTAFAIR gentamicin sulfate CREAM;TOPICAL 062458-001 Sep 1, 1983 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Citi
Healthtrust
Fish and Richardson
Teva
Cerilliant
Deloitte
Johnson and Johnson
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.